Voloridge Investment Management
SLDB icon

Voloridge Investment Management’s Solid Biosciences SLDB Stock Holding History

Voloridge Investment Management’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,515
Closed -$54K – 1475
2020
Q1 		$54K Buy
+1,515
New +$75K ﹤0.01% 1040
2019
Q2 		– Sell
-2,972
Closed -$410K – 1041
2019
Q1 		$410K Buy
+2,972
New +$745K 0.01% 719

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Voloridge Investment Management's SLDB Position: Q2 2020 in Review

Voloridge Investment Management sold out of Solid Biosciences (SLDB) in Q2 2020, closing a stake of 1,515 shares — an estimated $54K sold.

Voloridge Investment Management first reported a position in SLDB in Q1 2019 and held it in 2 quarters. The position peaked at $410K in Q1 2019. 66 funds tracked by Wall St. Rank hold SLDB as of Q2 2020.

  • Voloridge Investment Management reported no remaining Solid Biosciences position as of Q2 2020 after selling out during the quarter.
  • Voloridge Investment Management sold 1,515 Solid Biosciences shares in Q2 2020, an estimated $54K.
  • Voloridge Investment Management first reported a position in Solid Biosciences in Q1 2019 and held it in 2 quarters.
  • Voloridge Investment Management's Solid Biosciences position peaked at $410K in Q1 2019.
  • 66 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2020.

Based on Voloridge Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.